NCT06367816

Brief Summary

Thus far, the closed-loop ventilation mode INTELLiVENT-ASV has been extensively tested in various groups of critically ill patients, and has been shown to be effective and safe in various groups of ventilated patients, including those at risk of acute respiratory distress syndrome (ARDS), patients with ARDS, and patients with chronic obstructive pulmonary disease (COPD). Some of these studies included acute brain injury (ABI) patients, but the effectiveness, efficacy and safety of INTELLiVENT-ASV has never been thoroughly tested in these patients. The current study will investigate the effectiveness in providing both brain- and lung protective ventilation, the safety and the efficacy of a closed-loop ventilation mode (INTELLiVENT-ASV) in acute brain injury patients, using breath-by-breath data.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Apr 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 11, 2024

Completed
Same day until next milestone

Study Start

First participant enrolled

April 11, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 16, 2024

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

March 10, 2026

Status Verified

March 1, 2026

Enrollment Period

7 months

First QC Date

April 11, 2024

Last Update Submit

March 9, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Proportion of breaths in predefined zones of ventilation

    7 hours from baseline

  • Proportion of time in predefined zones of ventilation

    7 hours from baseline

Secondary Outcomes (19)

  • Intracerebral changes assessed by multimodal neuromonitoring available

    7 hours from baseline

  • Changes on Electrical Impedence Tomography when available

    7 hours from baseline

  • Effectiveness in primary ABI patients vs non primary ABI patients

    7 hours from baseline

  • Episodes and time of high maximum airway pressure

    7 hours from baseline

  • Episodes and time of high respiratory rate

    7 hours from baseline

  • +14 more secondary outcomes

Interventions

INTELLiVENTPROCEDURE

Closed-loop mode of ventilation

Mode of ventilation

Eligibility Criteria

Age18 Years - 105 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Invasively ventilated acute brain injury (ABI) patients admitted to the ICU of the Policlinico San Martino Hospital, Genova, Italy

You may qualify if:

  • aged ≥ 18 years;
  • intubated and receiving invasive ventilation for ABI;
  • admitted to the Intensive Care Unit

You may not qualify if:

  • \- receiving ventilation with a ventilator that does not allow INTELLiVENT-ASV

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UO Clinica Anestesiologica e Terapia Intensiva, IRCCS Ospedale Policlinico San Martino

Genova, GE, 16132, Italy

Location

Related Publications (1)

  • Goossen RL, Gavinelli S, Dragoni S, van Meenen DMP, Paulus F, Schultz MJ, Ball L, Patroniti NA, Robba C. Brain protective ventilation in acute brain injury patients with use of fully automated ventilation (BRAVE): A cross-over clinical trial. Eur J Anaesthesiol. 2026 Mar 1;43(3):235-244. doi: 10.1097/EJA.0000000000002253. Epub 2025 Aug 22.

MeSH Terms

Conditions

Brain InjuriesRespiratory Aspiration

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and InjuriesRespiration DisordersRespiratory Tract DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

April 11, 2024

First Posted

April 16, 2024

Study Start

April 11, 2024

Primary Completion

October 31, 2024

Study Completion

December 31, 2024

Last Updated

March 10, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations